EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action

Anna Not, Hakima Ouaarab-Essadek, Marcos Montoro, Begoña Treviño, María Buti, Rosa M Morillas, Antoni E Bordoy, Cinta Folch, Xavier Majó, Jordi Casabona, Jordi Gómez I Prat, Elisa Martró iD

Liver International · 2025-06 · 45 (6)

DOI: 10.1111/liv.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 12.05.2025. Verfasst von Anna Not und 11 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Microbiology Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis B, Mass Screening, Transients and Migrants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Social Fund, Instituto de Salud Carlos III, European Social Fund Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Migrants from endemic areas are key populations for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection screening in Europe. This study assessed the feasibility and outcomes of a community action that combined education, screening, and simplified access to care for migrants in Barcelona.

Methods

Adult migrants from Pakistan, Romania, and Senegal were included from 2021 to 2023, through a community action involving education, an epidemiological questionnaire, and rapid testing for HBV surface antigen (HBsAg) and HCV antibodies. If positive, DBS samples were collected for laboratory confirmation. Viremic cases were referred to an International Health Unit (IHU).

Results

Overall, 786 participants were included (346 from Pakistan, 304 from Senegal and 136 from Romania). Previous screening for HBV and HCV was 8.0% and 7.7%, respectively. HBsAg prevalence was 0.9% for migrants from Pakistan, 8.2% for those from Senegal and 1.4% for those from Romania ( n = 30/786, 23 new diagnoses). Among these, 69.6% attended the IHU and were HBV‐DNA positive, but none met treatment criteria. Anti‐HCV prevalence was 3.5%, 0.7% and 1.4% for migrants from Pakistan, Senegal and Romania, respectively ( n = 16/768, 12 new diagnoses), and HCV‐RNA prevalence was 0.9%, 0.3% and 0.7%, respectively ( N = 6, all new diagnoses); 4 (66.6%) cases were linked to treatment and two were cured.

Conclusions

This novel community action successfully reached migrants in a situation of vulnerability and provided them access to testing and care. The high prevalence observed and the limited self‐knowledge of their HBV and HCV status justify targeted screening in these groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHepatitis BMass ScreeningTransients and MigrantsHumansAdultMaleFemaleSpainRomaniaMiddle AgedHepatitis B Surface AntigensSenegalPakistanPrevalenceHepatitis C AntibodiesHealth Services AccessibilityYoung AdultEndemic Diseases

Stichwörter der Autor:innen

community actiondried blood spots (DBS)hepatitis B virus (HBV)hepatitis C virus (HCV)migrants

Substanzen

Hepatitis B Surface AntigensHepatitis C Antibodies

Autor:innen und Institutionen

  • Genetics and Microbiology Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Microbiology Department, Laboratori Clínic Metropolitana Nord (LCMN), Germans Trias i Pujol Research Institute and Hospital (IGTP), Barcelona, Spain.
  • Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Community & Public Health Team (ESPIC), Drassanes-Vall D'hebron Centre for International Health and Infectious Diseases, Barcelona, Spain.
  • Centre d'Estudis Epidemiològics Sobre les ITS i la Sida de Catalunya (CEEISCAT), Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Spain.
  • Hepatology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.

ORCID-Profile: Elisa Martró

Förderung

  • European Social Fund
  • Instituto de Salud Carlos III
  • European Social Fund Plus

Zitieren

APA

Not, A., Ouaarab-Essadek, H., Montoro, M., Treviño, B., Buti, M., Morillas, R. M., Bordoy, A. E., Folch, C., Majó, X., Casabona, J., Prat, J. G. I., & Martró, E. (2025). Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action. Liver International, 45(6). https://doi.org/10.1111/liv.70126

Vancouver

Not A, Ouaarab-Essadek H, Montoro M, Treviño B, Buti M, Morillas RM, et al. Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action. Liver International. 2025;45(6). doi:10.1111/liv.70126

BibTeX
@article{Not2025,
  author = {Not, Anna and Ouaarab-Essadek, Hakima and Montoro, Marcos and Treviño, Begoña and Buti, María and Morillas, Rosa M and Bordoy, Antoni E and Folch, Cinta and Majó, Xavier and Casabona, Jordi and Prat, Jordi Gómez I and Martró, Elisa},
  title = {Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {6},
  doi = {10.1111/liv.70126}
}
Kostenlos starten →